GPI 1485

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00076492 (ClinicalTrials.gov)	January 2004	23/1/2004	NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485	A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485in Subjects With Early Untreated Park ...	Parkinson Disease	Drug: CoQ10;Drug: GPI 1485	University of Rochester	National Institute of Neurological Disorders and Stroke (NINDS)	Completed	30 Years	N/A	Both	195	Phase 2	United States
2	NCT00209508 (ClinicalTrials.gov)	November 2002	13/9/2005	2 Year Study to Evaluate the Effects of GPI 1485on [123I]b-CIT/SPECTScanning and Clinical Efficacy i ...	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects O ...	Parkinson's Disease	Drug: GPI 1485	Eisai Inc.	Symphony Neuro Development Company	Completed	40 Years	80 Years	Both	200	Phase 2	NULL

First Previous1Next Last